本頁面由Tiger Trade Technology Pte. Ltd.提供服務

泰和誠醫療

5.29
+0.04000.76%
盤後5.290.00000.00%16:04 EDT
成交量:2.77萬
成交額:14.84萬
市值:2,296.76萬
市盈率:-1.74
高:5.52
開:5.11
低:5.07
收:5.25
52周最高:6.98
52周最低:3.18
股本:434.17萬
流通股本:138.21萬
量比:0.12
換手率:2.01%
股息:- -
股息率:- -
每股收益(TTM):-3.0453
每股收益(LYR):-3.0453
淨資產收益率:-21.88%
總資產收益率:-2.25%
市淨率:-0.07
市盈率(LYR):-1.74

資料載入中...

2026/04/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/04/25

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/17

SEC問詢函

Form CORRESP - Correspondence
2023/07/14

SEC問詢函

Form CORRESP - Correspondence
2023/04/19

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/26

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/19

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/16

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/08/30

非美公司披露報告